rs201320564
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PVS1PP3PP5_Very_Strong
The NM_019098.5(CNGB3):c.1432C>T(p.Arg478*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,613,762 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R478R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_019098.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- achromatopsia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia
- CNGB3-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- achromatopsiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- severe early-childhood-onset retinal dystrophyInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CNGB3 | ENST00000320005.6 | c.1432C>T | p.Arg478* | stop_gained | Exon 12 of 18 | 1 | NM_019098.5 | ENSP00000316605.5 | ||
| CNGB3 | ENST00000681546.1 | n.1252C>T | non_coding_transcript_exon_variant | Exon 7 of 13 | ||||||
| CNGB3 | ENST00000681746.1 | n.1432C>T | non_coding_transcript_exon_variant | Exon 12 of 19 | ENSP00000505959.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000199 AC: 5AN: 251100 AF XY: 0.0000221 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461702Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 10AN XY: 727152 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152060Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74280 show subpopulations
ClinVar
Submissions by phenotype
Achromatopsia Pathogenic:2
- -
- -
Achromatopsia 3 Pathogenic:1
- -
not provided Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg478*) in the CNGB3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CNGB3 are known to be pathogenic (PMID: 28795510). This variant is present in population databases (rs201320564, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with achromatopsia (PMID: 15657609, 28795510). ClinVar contains an entry for this variant (Variation ID: 427692). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Retinal dystrophy Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at